Skip to main content
. 2016 Mar 30;7(18):26388–26399. doi: 10.18632/oncotarget.8506

Table 1. Relationship between miR-149 expression and clinical pathological factors in glioma cancer.

Variable Patients negative positive p value
+ ++ +++
Gender
 Male 50 13 (26%) 28 8 1 0.3152 a
 Female 32 6 (18.8%) 19 7 0
Age
 < = 40 36 5 (13.9%) 23 7 1 0.1135 a
 > 40 46 14 (30.4%) 24 8 0
Pathological stage
 normal 10 4 (40%) 2 3 1 0.0084 a
 tumor 72 15 (20.8%) 45 12 0
  1 7 0 (0.0%) 4 3 0 0.0114 a
  II 47 15 (31.9%) 24 8 0
  III 9 0 (0.0%) 8 1 0
  IV 9 0 (0.0%) 9 0 0
a

Two-sided Fisher's Exact Test.